KK
VNDA icon

KLP Kapitalforvaltning’s Vanda Pharmaceuticals VNDA Stock Holding History

KLP Kapitalforvaltning’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$829K Hold
135,400
– – ﹤0.01% 1234
2026
Q1 		$936K Hold
135,400
– – ﹤0.01% 1064
2025
Q4 		$1.19M Hold
135,400
– – ﹤0.01% 940
2025
Q3 		$676K Hold
135,400
– – ﹤0.01% 1251
2025
Q2 		$639K Hold
135,400
– – ﹤0.01% 1225
2025
Q1 		$621K Hold
135,400
– – ﹤0.01% 1178
2024
Q4 		$649K Buy
+135,400
New +$650K ﹤0.01% 1213

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's VNDA Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 135,400 shares worth $829K. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

KLP Kapitalforvaltning first reported a position in VNDA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.19M in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • KLP Kapitalforvaltning held 135,400 shares of Vanda Pharmaceuticals worth $829K as of Q2 2026.
  • KLP Kapitalforvaltning left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1234 holding.
  • KLP Kapitalforvaltning first reported a position in Vanda Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Vanda Pharmaceuticals position peaked at $1.19M in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.